Andreas Rummelt, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 5,052 shares at $170.53 ($862K) on 2014-08-25, disclosed to the SEC on 2014-08-27.
Open-market sale of $862k ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2012-02-23 | $537K | — | Filing → |
| ALXN | SELL | 2011-10-25 | $622K | — | Filing → |
| ALXN | BUY | 2010-05-12 | $263K | — | Filing → |